하모니 바이오사이언스 홀딩스, Inc.
US ˙ NasdaqGM ˙ US4131971040

SecurityHRMY / Harmony Biosciences Holdings, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership115,474 shares
Latest Disclosed Value $ 4,321,036
Barclays Plc reports 3.55% increase in ownership of HRMY / Harmony Biosciences Holdings, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 115,474 shares of Harmony Biosciences Holdings, Inc. (US:HRMY) valued at $4,321,037 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 111,514 shares of Harmony Biosciences Holdings, Inc.. This represents a change in shares of 3.55% during the quarter. The current value of the position is $3,718,263 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F HARMONY BIOSCIENCES HLDGS IN COM 413197104 115,474 3,960 3.55 4,321 40.61 0.0010
2026-03-31 2025-09-30 13F/A-3 HARMONY BIOSCIENCES HLDGS IN COM 413197104 111,514 -15,599 -12.27 3,073 -23.48 0.0007
2026-03-19 2025-09-30 13F/A-2 HARMONY BIOSCIENCES HLDGS IN COM 413197104 76,862 -50,251 3,074 0.0008
2025-11-12 2025-09-30 13F HARMONY BIOSCIENCES HLDGS IN COM 413197104 111,514 -15,599 3,073 0.0007
2026-02-27 2025-06-30 13F/A-2 HARMONY BIOSCIENCES HLDGS IN COM 413197104 127,113 43,823 52.61 4,017 45.30 0.0009
2025-08-14 2025-06-30 13F/A-1 HARMONY BIOSCIENCES HLDGS IN COM 413197104 127,113 43,823 4 0.0009
2025-08-13 2025-06-30 13F HARMONY BIOSCIENCES HLDGS IN COM 413197104 127,113 43,823 4 0.0003
2026-03-17 2025-03-31 13F/A-1 HARMONY BIOSCIENCES HLDGS IN COM 413197104 83,290 -17,582 -17.43 2,764 -20.37 0.0008
2025-05-15 2025-03-31 13F HARMONY BIOSCIENCES HLDGS IN COM 413197104 83,290 -17,582 3 0.0008
2026-03-19 2024-12-31 13F/A-1 HARMONY BIOSCIENCES HLDGS IN COM 413197104 100,872 24,010 31.24 3,471 12.91 0.0010
2025-02-13 2024-12-31 13F HARMONY BIOSCIENCES HLDGS IN COM 413197104 100,872 24,010 3 0.0010
2026-03-31 2024-09-30 13F/A-2 HARMONY BIOSCIENCES HLDGS IN COM 413197104 76,862 40,416 110.89 3,074 179.71 0.0008
2024-11-19 2024-09-30 13F/A-1 HARMONY BIOSCIENCES HLDGS IN COM 413197104 76,862 40,416 3 0.0008
2024-11-15 2024-09-30 13F HARMONY BIOSCIENCES HLDGS IN COM 413197104 76,862 40,416 3 0.0002
2026-03-23 2024-06-30 13F/A-1 HARMONY BIOSCIENCES HLDGS IN COM 413197104 36,446 -13,498 -27.03 1,100 -34.47 0.0003
2024-08-14 2024-06-30 13F HARMONY BIOSCIENCES HLDGS IN COM 413197104 36,446 -13,498 1 0.0003
2026-03-24 2024-03-31 13F/A-1 HARMONY BIOSCIENCES HLDGS IN COM 413197104 49,944 -21,314 -29.91 1,677 -27.12 0.0006
2024-05-15 2024-03-31 13F HARMONY BIOSCIENCES HLDGS IN COM 413197104 49,944 -21,314 2 0.0006
2026-03-25 2023-12-31 13F/A-1 HARMONY BIOSCIENCES HLDGS IN COM 413197104 71,258 37,069 108.42 2,302 105.45 0.0008
2024-02-15 2023-12-31 13F HARMONY BIOSCIENCES HLDGS IN COM 413197104 71,258 37,069 2 0.0008
2026-03-26 2023-09-30 13F/A-1 HARMONY BIOSCIENCES HLDGS IN COM 413197104 34,189 4,461 15.01 1,120 7.07 0.0007
2023-11-07 2023-09-30 13F HARMONY BIOSCIENCES HLDGS IN COM 413197104 34,189 4,461 1 0.0007
2026-03-30 2023-06-30 13F/A-2 HARMONY BIOSCIENCES HLDGS IN COM 413197104 29,728 750 2.59 1,046 10.57 0.0007
2023-09-20 2023-06-30 13F/A-1 HARMONY BIOSCIENCES HLDGS IN COM 413197104 29,728 750 1 0.0007
2023-08-03 2023-06-30 13F HARMONY BIOSCIENCES HLDGS IN COM 413197104 29,728 750 1 0.0007
2026-03-30 2023-03-31 13F/A-1 HARMONY BIOSCIENCES HLDGS IN COM 413197104 28,978 5,719 24.59 946 -26.15 0.0004
2023-05-04 2023-03-31 13F HARMONY BIOSCIENCES HLDGS IN COM 413197104 28,978 5,719 1 0.0004
2026-03-30 2022-12-31 13F/A-1 HARMONY BIOSCIENCES HLDGS IN COM 413197104 23,259 -881 -3.65 1,282 19.94 0.0006
2023-02-13 2022-12-31 13F HARMONY BIOSCIENCES HLDGS IN COM 413197104 23,259 -881 1 0.0006
2022-11-03 2022-09-30 13F HARMONY BIOSCIENCES HLDGS IN COM 413197104 24,140 1,383 6.08 1,068 -3.78 0.0012
2022-08-12 2022-06-30 13F HARMONY BIOSCIENCES HLDGS IN COM 413197104 22,757 -4,422 -16.27 1,110 -15.97 0.0007
2022-05-16 2022-03-31 13F HARMONY BIOSCIENCES HLDGS IN COM 413197104 27,179 27,179 1,321 0.0010
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.